Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 3, 2021Expert Opinion on Therapeutic TargetsOpen Access

Hepatocellular carcinoma (HCC): the most promising therapeutic targets in the preclinical arena based on tumor biology characteristics

View Full Paper
Ask AI
Bookmark
Share

Authors

HWHaichuan WangXCXin ChenDCDiego F. Calvisi

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Wang et al. (2021) studied this question.

synapsesocial.com/papers/6a75a99d362ed8827e6a39bbhttps://doi.org/10.1080/14728222.2021.1976142
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Anti-GPC3-CAR T Cells Suppress the Growth of Tumor Cells in Patient-Derived Xenografts of Hepatocellular Carcinoma2017 · 209 citations
  2. 2Hepatocellular Carcinoma2019 · 4,746 citations
  3. 3Mitochondrial Dysfunction in the Transition from NASH to HCC2019 · 93 citations
  4. 4PI16 attenuates response to sorafenib and represents a predictive biomarker in hepatocellular carcinoma2020 · 17 citations
  5. 5Nrf2 Mutagenic Activation Drives Hepatocarcinogenesis2017 · 84 citations